Edition:
United States

Zosano Pharma Corp (ZSAN.OQ)

ZSAN.OQ on NASDAQ Stock Exchange Capital Market

4.38USD
20 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.38
Open
$4.40
Day's High
$4.50
Day's Low
$4.35
Volume
19,875
Avg. Vol
132,541
52-wk High
$27.40
52-wk Low
$3.63

Chart for

About

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved... (more)

Overall

Beta: 1.96
Market Cap(Mil.): $52.44
Shares Outstanding(Mil.): 11.97
Dividend: --
Yield (%): --

Financials

  ZSAN.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -15.41 -- --
ROI: -181.95 -3.65 13.18
ROE: -220.43 -5.62 15.09

BRIEF-Zosano Appoints Steven Elms To Board Of Directors

* ZOSANO PHARMA CORP - STEVEN A. ELMS, MANAGING PARTNER AT AISLING CAPITAL, HAS BEEN APPOINTED TO COMPANY'S BOARD

May 22 2018

BRIEF-Zosano Pharma Q1 Loss Per Share $4.16

* ZOSANO PHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL UPDATE

May 15 2018

BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study

* ZOSANO REACHES ANOTHER ENROLLMENT MILESTONE IN M207-ADAM LONG-TERM SAFETY STUDY

May 14 2018

BRIEF-Zosano Announces Pricing Of 10 Mln Common Shares At $5 per Share

* ZOSANO ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

Mar 29 2018

BRIEF-Zosano Pharma Corp Files For Offering 10 Mln Shares Of Co's Common Stock‍​

* ZOSANO PHARMA CORP FILES FOR OFFERING 10 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING‍​ Source text: [https://bit.ly/2J2rCA6] Further company coverage:

Mar 28 2018

BRIEF-Zosano Pharma Corp Files ‍Prospectus Related To Offering Of 3.23 mln Shares Co's Common Stock

* ZOSANO PHARMA CORP FILES PROSPECTUS RELATED TO OFFERING OF 3.23 MILLION SHARES CO'S COMMON STOCK - SEC FILING​ Source text - https://bit.ly/2pFJlFL Further company coverage:

Mar 26 2018

BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study

* ZOSANO REACHES ENROLLMENT MILESTONE IN M207-ADAM LONG-TERM SAFETY STUDY

Mar 16 2018

BRIEF-Zosano Pharma Reports Q4 Loss Per Share $3.80

* ZOSANO PHARMA REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL UPDATE

Mar 12 2018

BRIEF-Zosano Pharma Announces Issuance Of New U.S. Patent Covering M207 As An Acute Treatment For Migraine

* ZOSANO PHARMA ANNOUNCES ISSUANCE OF NEW U.S. PATENT COVERING M207 AS AN ACUTE TREATMENT FOR MIGRAINE Source text for Eikon: Further company coverage:

Mar 02 2018

BRIEF-Zosano Pharma Files Prospectus Related Offering 12.5 Mln Shares

* ZOSANO PHARMA CORP FILES PROSPECTUS RELATED OFFERING 12.5 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text: (http://bit.ly/2EDTBag) Further company coverage:

Feb 13 2018

Earnings vs. Estimates